Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Nimtuzumab：400mg,i.v.,once a week,until tumor progression、Death or untalerable toxicity

Use it as it is describe in the instructions from the specification